When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Tuberculosis vaccines - Wikipedia

    en.wikipedia.org/wiki/Tuberculosis_vaccines

    Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch . [ 1 ] As of 2021, the only effective tuberculosis vaccine in common use is the Bacillus Calmette-Guérin (BCG) vaccine, first used on humans in 1921.

  3. What Doctors Want You to Know About the TB Vaccine - AOL

    www.aol.com/doctors-want-know-tb-vaccine...

    A tuberculosis (TB) outbreak in Kansas is raising a lot of questions about the bacterial infection, with ways to prevent infection at the forefront of people’s minds, having many wondering if ...

  4. M72/AS01E - Wikipedia

    en.wikipedia.org/wiki/M72/AS01E

    M72/AS01 E is an experimental tuberculosis vaccine. If approved, it would be the first vaccine for tuberculosis in more than a century after the BCG vaccine. [1] [2] The vaccine consists of two main ingredients. The antigen part is M72, a recombinant fusion protein derived from the sequences of two M. tuberculosis antigens (Mtb32A and Mtb39A ).

  5. BCG vaccine - Wikipedia

    en.wikipedia.org/wiki/BCG_vaccine

    The Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). [9] It is named after its inventors Albert Calmette and Camille Guérin. [10] [11] In countries where tuberculosis or leprosy is common, one dose is recommended in healthy babies as soon after birth as possible. [9]

  6. Tuberculosis - Wikipedia

    en.wikipedia.org/wiki/Tuberculosis

    In primary TB disease (some 1–5% of cases), this occurs soon after the initial infection. [13] However, in the majority of cases, a latent infection occurs with no obvious symptoms. [13] These dormant bacilli produce active tuberculosis in 5–10% of these latent cases, often many years after infection. [48]

  7. MVA85A - Wikipedia

    en.wikipedia.org/wiki/MVA85A

    MVA85A (modified vaccinia Ankara 85A) is a vaccine against tuberculosis developed by researchers led by Professor Helen McShane at Oxford University. [1] It is a viral vector vaccine and consists of an MVA virus engineered to express the 85A antigen once it infects a host cell. 85A is a cell-wall protein of the tuberculosis bacillus.

  8. Management of tuberculosis - Wikipedia

    en.wikipedia.org/wiki/Management_of_tuberculosis

    Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB. The medical standard for active TB is a short course treatment involving a combination of isoniazid , rifampicin (also known as Rifampin), pyrazinamide , and ethambutol for the first two months.

  9. More than 500 people asked to test for tuberculosis after ...

    www.aol.com/news/more-500-people-asked-test...

    The Douglas County Health Department said anyone who had close contact with the infected person from May 30 through Oct. 30 should get tested for tuberculosis bacteria, which can spread through ...